Deficit of CD47 results in a defect of marginal zone dendritic cells, blunted immune response to particulate antigen and impairment of skin dendritic cell migration

Journal of Immunology

Volumn 176, Issue 10, 2006, Pages 5772-5778

  Hagnerud, Sven ^a   Manna, Partha Pratim ^b   Cella, Marina ^b   Stenberg, Åsa ^a   Frazier, William A ^b   Colonna, Marco ^b   Oldenborg, Per Arne ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD4 ANTIGEN; CD47 ANTIGEN; CD8ALPHA ANTIGEN; CELL ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CCR7; GLYCOPROTEIN P 15095; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SIGNAL REGULATORY PROTEIN ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL COUNT; CELL MATURATION; CELL MIGRATION; CONTACT SENSITIZATION; CONTROLLED STUDY; DENDRITIC CELL; EPIDERMIS; GRANULOCYTE; IMMUNE RESPONSE; LYMPH NODE; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 33646491871     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.10.5772     Document Type: Article

References (34)

1. Brown, E. J., and W. A. Frazier. 2001. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 11: 130-135.
2. Lindberg, F. P., D. C. Bullard, T. E. Caver, H. D. Gresham, A. L. Beaudet, and E. J. Brown. 1996. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 274: 795-798.
3. Zen, K., and C. A. Parkos. 2003. Leukocyte-epithelial interactions. Curr. Opin. Cell Biol. 15: 557-564.
4. Reinhold, M. I., F. P. Lindberg, G. J. Kersh, P. M. Allen, and E. J. Brown. 1997. Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. J. Exp. Med. 185: 1-11.
5. Jiang, P., C. F. Lagenaur, and V. Narayanan. 1999. Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J. Biol. Chem. 274: 559-562.
6. Vernon-Wilson, E. F., W. J. Kee, A. C. Willis, A. N. Barclay, D. L. Simmons, and M. H. Brown. 2000. CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPα1. Eur. J. Immunol. 30: 2130-2137.
7. Oshima, K., A. R. Ruhul Amin, A. Suzuki, M. Hamaguchi, and S. Matsuda. 2002. SHPS-1, a multifunctional transmembrane glycoprotein. FEBS Lett. 519: 1-7.
8. Oldenborg, P.-A., A. Zheleznyak, Y.-F. Fang, C. F. Lagenaur, H. D. Gresham, and F. P. Lindberg. 2000. Role of CD47 as a marker of self on red blood cells. Science 288: 2051-2054.
9. de Vries, H. E., J. J. Hendriks, H. Honing, C. R. De Lavalette, S. M. van der Pol, E. Hoijberg, C. D. Dijkstra, and T. K. van den Berg. 2002. Signal-regulatory protein a-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. J. Immunol. 168: 5832-5839.
10. Vignery, A. 2000. Osteoclasts and gigant cells: macrophage-macrophage fusion mechanisms. Int. J. Exp. Pathol. 81: 291-304.
11. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
12. Steinman, R. M., M. Pack, and K. Inaba. 1997. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156: 25-37.
13. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2: 151-161.
14. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CDS expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164: 2978-2986.
15. Witmer, M. D., and R. M. Steinman. 1984. The anatomy of peripheral lymphoid organs with emphasis on accessory cells: light-microscopic immunocytochemical studies of mouse spleen, lymph node, and Peyer's patch. Am. J. Anat. 170: 465-481.
16. Fukunaga, A., H. Nagai, T. Noguchi, H. Okazawa, T. Matozaki, X. Yu, C. F. Lagenaur, N. Honma, M. Ichihashi, M. Kasuga, et al. 2004. Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the migration of Langerhans cells from the epidermis to draining lymph nodes. J. Immunol. 172: 4091-4099.
17. Bimczok, D., E. N. Sowa, H. Faber-Zuschatter, R. Pabst, and H. J. Rothkotter. 2005. Site-specific expression of CD11b and SIRPα (CD172a) on dendritic cells: implications for their migration patterns in the gut immune system. Eur. J. Immunol. 35: 1418-1427.
18. Epardaud, M., M. Bonneau, F. Payot, C. Cordier, J. Megret, C. J. Howard, and I. Schwartz-Cornil. 2004. Enrichment for a CD26hi SIRP- subset in lymph dendritic cells from the upper aero-digestive tract. J. Leukocyte Biol. 76: 553-561.
19. Yrlid, U., and G. G. MacPherson. 2003. Phenotype and function of rat dendritic cell subsets. APMlS 111: 756-765.
20. Demeure, C., H. Tanaka, V. Mateo, M. Rubin, G. Delespesse, and M. Sarfati. 2000. CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J. Immunol. 164: 2193-2199.
21. Doyen, V., M. Rubio, D. Braun, T. Nakajima, J. Abe, H. Saito, G. Delespesse, and M. Sarfati. 2003. Thrombospondin is an autocrine negative regulator of human dendritic cell activation. J. Exp. Med. 198: 1277-1283.
22. Latour, S., H. Tanaka, C. Demeure, V. Mateo, M. Rubio, E. J. Brown, C. Maliszewski, F. P. Lindberg, A. Oldenborg, A. Ullrich, et al. 2001. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-α: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J. Immunol, 167: 2547-2554.
23. Heyman, B., G. Holmquist, P. Borwell, and U. Heyman. 1984. An enzyme-linked immunosorbent assay for measuring anti-sheep erythrocyte antibodies. J. Immunol Methods 68: 193-204.
24. Martin, F., and J. F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2: 323-335.
25. Cyster, J. G. 1999. Chemokines and cell migration in secondary lymphoid organs. Science 286: 2098-2102.
26. Dieu, M. C., B. Vanbervliet, A. Vicari, J. M. Bridon, E. Oldham, S. Ait-Yaha, F. Briere, A. Zlotnik, S. Lebecque, and C. Caux. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188: 373-386.
27. Ohl, L., M. Mohaupt, N. Czeloth, G. Hintzen, Z. Kifard, J. Zwirner, T. Blankenstein, G. Henning, and R. Förster. 2004. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21: 279-288.
28. Kamath, A. T., J. Pooley, M. A. O'Keeffe, D. Vremec, Y. Zhan, A. M. Lew, A. D. D'Amico, L. Wu, D. F. Tough, and K. Shortman. 2000. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 165: 6762-6770.
29. Merad, M., M. G. Manz, H. Karsunky, A. Wagers, W. Peters, I. Charo, I. L. Weissman, J. G. Cyster, and E. G. Engelman. 2002. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3: 1135-1141.
30. Liu, Y., H.-J. Bühring, K. Zen, S. L. Burst, F. J. Schnell, I. R. Williams, and C. A. Parkos. 2002. Signal regulatory protein (SIRPα), a cellular ligand for CD47, regulates neutrophil transmigration. J. BM. Chem. 277: 10028-10036.
31. Ma, J., J. H. Wang, Y. J. Guo, M. S. Sy, and M. Bigby. 1994. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell Immunol. 158: 389-399.
32. Xu, H., H. Guan, G. Zu, D. Bullard, J. Hanson, M. Slater, and C. A. Elmets. 2001. The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur. J. Immunol. 31: 3085-3092.
33. Price, A. A., M. Cumberbatch, I. Kimber, and A. Ager. 1997. á6 integrins are required for Langerhans cell migration from the epidermis. J. Exp. Med. 186: 1725-1735.
34. Grabbe, S., G. Varga, S. Beissert, M. Steinert, G. Pendl, S. Seeliger, W. Bloch, T. Peters, T. Schwarz, C. Sunderkotter, and K. Scharffetter-Kochanek. 2002. β2 integrins are required for skin homing of primed T cells but not for priming naive T cells. J. Clin. Invest. 109: 183-192.